Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report

BACKGROUND: Voriconazole (VRCZ) is the first-line therapy for chronic pulmonary aspergillosis and is available in both intravenous and oral formulations. The bioavailability of the oral form is estimated to be over 90% in healthy volunteers. Some drugs are reported to interact with enteral nutrition...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Hiromi, Yamazaki, Shingo, Uchida, Masashi, Suzuki, Takaaki, Murakami, Kentaro, Matsubara, Hisahiro, Kamei, Katsuhiko, Ishii, Itsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812174/
https://www.ncbi.nlm.nih.gov/pubmed/35109934
http://dx.doi.org/10.1186/s40780-021-00237-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812174/
https://www.ncbi.nlm.nih.gov/pubmed/35109934
http://dx.doi.org/10.1186/s40780-021-00237-4

Ejemplares similares